What's been impacting the Ramsay Health share price this week?

The hospital operator has decided to go its own way…

| More on:
Doctor reading a file

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points

  • The Ramsay Health Care share price is slightly lower today, at $70.50 
  • Shares have remained relatively steady despite the breakdown of an agreement with major health insurer Bupa
  • However, Bupa and Ramsay are still on speaking terms

The Ramsay Health Care Limited (ASX: RHC) share price has been stubborn this week. This is despite news of the termination of the company's agreement with health insurance provider Bupa. 

On the day of the announcement yesterday, the Ramsay share price closed at $70.57, slightly lower than its previous close. Currently, shares in the private healthcare operator are down 0.09% to $70.50 apiece.

Why the Ramsay share price held steady

Negative news tends to push down a company's share price. But in this instance, Ramsay had already flagged its notice of termination of the Bupa contract in May. So, the market saw this coming. 

Yesterday, Ramsay confirmed it could not reach a resolution on key terms of a new contract. As such, it decided to part ways.

For patients of Ramsay who are insured with Bupa, the termination means the contractual and agreed transitional arrangements apply for a period of at least 60 days. As a result, a Bupa-insured customer is required to pay the difference between what Bupa pays out and Ramsay's total hospital fees. 

Ramsay also noted it is liaising with impacted patients to assist with providing alternatives, which include changing health funds. 

Although the agreement has been terminated, both parties are still on speaking terms in the hope of striking a new agreement.

The rise of private health insurers

According to a statement by the Australian Medical Association (AMA) in May 2022, "some larger private health insurers were increasingly trying to use their market power to squeeze private hospital operators in order to improve their own bottom line".

Evidently, Ramsay is not budging given its market position. However, this could prove to be a risky move amid the continued shortage of nurses pushing up wage expenses, as well as supply chain pressures. 

Meanwhile, private health insurers have benefited from the pandemic, boosting their bottom line over the last two years. 

It appears private health insurers are in a better position to negotiate terms and if more negotiations break down, it could mean Ramsay is facing a genuine power shift over the short to medium term. 

As a result, this could spell trouble for the Ramsay share price. The company might need to pay more to private health insurers to secure patients, leading to lower returns on capital.

Monitoring the market share of the dominant private health insurers could be a sound method of determining who is winning the arm wrestle.

Motley Fool contributor Raymond Jang has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Ramsay Health Care Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

a biomedical researcher sits at his desk with his hand on his chin, thinking and giving a small smile with a microscope next to him and an array of test tubes and beackers behind him on shelves in a well-lit bright office.
Healthcare Shares

Broker says this ASX 200 biotech stock is a top buy

Let's see what Bell Potter is saying about this biotech.

Read more »

Cropped shot of an attractive young female scientist working on her computer in the laboratory.
Healthcare Shares

Why CSL shares are a buy today despite the looming Trump tariffs

A leading expert believes CSL shares are still trading for a bargain today. Here's why.

Read more »

A businesswoman pulls her glasses down in shock to look at the bad news on her computer.
Healthcare Shares

Why did the Telix share price just crash 16%?

Investors are sending the Telix share price plunging today. But why?

Read more »

Broker analysing the share price.
Healthcare Shares

Expert: 2 ASX healthcare stocks to avoid before reporting season

Not all healthcare stocks are created equal.

Read more »

A group of people in a corporate setting do a collective high five.
Healthcare Shares

Should I buy Pro Medicus or CSL shares ahead of earnings season?

The ASX healthcare sector may be currently undervalued.

Read more »

Overjoyed man celebrating success with yes gesture after getting some good news on mobile.
Healthcare Shares

Why Mesoblast shares can keep storming higher

More big returns could be on the way for buyers of this high risk stock according to Bell Potter.

Read more »

Doctor doing a telemedicine using laptop at a medical clinic
Healthcare Shares

The Mesoblast share price just rocketed 38%! Here's why

ASX investors just sent the Mesoblast share price up 38%. But why?

Read more »

couple having a happy discussion with a banker
Healthcare Shares

Expert: 4 ASX healthcare stocks to buy ahead of reporting season

Could these ASX healthcare stocks be good additions to your portfolio?

Read more »